News & Updates
Filter by Specialty:
Show Multimedia Only

Semaglutide extends benefits in obesity-associated knee OA
22 Jan 2025
byAudrey Abella
In individuals with obesity and moderate-to-severe pain due to knee osteoarthritis (OA), treatment with the GLP-1 RA* semaglutide led to significantly greater reductions in body weight and pain related to knee OA as opposed to placebo, findings from the STEP** 9 trial suggest.